X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (540) 540
Book Chapter (341) 341
Newspaper Article (95) 95
Book / eBook (12) 12
Book Review (12) 12
Magazine Article (5) 5
Dissertation (3) 3
Patent (2) 2
Reference (2) 2
Trade Publication Article (2) 2
Conference Proceeding (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (300) 300
science & technology (295) 295
life sciences & biomedicine (287) 287
female (281) 281
oncology (229) 229
breast neoplasms - drug therapy (186) 186
breast cancer (164) 164
middle aged (157) 157
breast neoplasms - pathology (111) 111
aged (106) 106
adult (101) 101
chemotherapy, adjuvant (75) 75
treatment outcome (70) 70
antineoplastic combined chemotherapy protocols - therapeutic use (67) 67
cancer (64) 64
chemotherapy (54) 54
breast neoplasms - mortality (53) 53
disease-free survival (52) 52
tamoxifen - therapeutic use (52) 52
abridged index medicus (49) 49
antineoplastic agents, hormonal - therapeutic use (47) 47
care and treatment (47) 47
prognosis (47) 47
postmenopause (46) 46
clinical trials (45) 45
neoplasm staging (40) 40
medicine & public health (38) 38
risk factors (36) 36
tamoxifen (36) 36
general & internal medicine (35) 35
medicine, general & internal (35) 35
aged, 80 and over (34) 34
research (34) 34
breast neoplasms - metabolism (33) 33
breast neoplasms - genetics (32) 32
quality of life (32) 32
aromatase inhibitors - therapeutic use (31) 31
breast neoplasms - surgery (31) 31
randomized controlled trials as topic (31) 31
antineoplastic agents - therapeutic use (30) 30
survival analysis (30) 30
breast neoplasms - therapy (28) 28
kaplan-meier estimate (28) 28
male (28) 28
follow-up studies (27) 27
hematology, oncology and palliative medicine (27) 27
analysis (26) 26
drug therapy (25) 25
neoplasm metastasis (25) 25
adjuvant treatment (24) 24
antineoplastic combined chemotherapy protocols - adverse effects (24) 24
combined modality therapy (24) 24
health aspects (23) 23
menopause (23) 23
lymphatic metastasis (21) 21
endocrine therapy (20) 20
proportional hazards models (20) 20
nitriles - therapeutic use (19) 19
premenopause (19) 19
receptor, erbb-2 - metabolism (19) 19
receptors, estrogen - analysis (19) 19
time factors (19) 19
triazoles - therapeutic use (19) 19
aromatase inhibitors (18) 18
drug administration schedule (18) 18
receptors, estrogen - metabolism (18) 18
postmenopausal women (17) 17
breast neoplasms - blood (16) 16
breast neoplasms - chemistry (16) 16
clinical trials as topic (16) 16
prospective studies (16) 16
survival (16) 16
tumors (16) 16
womens health (16) 16
antineoplastic agents - adverse effects (15) 15
aromatase inhibitors - adverse effects (15) 15
cancer therapies (15) 15
estrogen (15) 15
patient selection (15) 15
predictive value of tests (15) 15
surveys and questionnaires (15) 15
survival rate (15) 15
tamoxifen - administration & dosage (15) 15
women (15) 15
breast neoplasms - diagnosis (14) 14
breast neoplasms - epidemiology (14) 14
breast neoplasms - prevention & control (14) 14
cancer patients (14) 14
cohort studies (14) 14
cyclophosphamide - administration & dosage (14) 14
fluorouracil - administration & dosage (14) 14
medical research (14) 14
patients (14) 14
trastuzumab (14) 14
antineoplastic agents (13) 13
canada (13) 13
double-blind method (13) 13
metastasis (13) 13
neoplasm recurrence, local (13) 13
receptors, progesterone - metabolism (13) 13
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Stacks (1) 1
Music - Stacks (1) 1
Online Resources - Online (1) 1
Providence Healthcare - Stacks (1) 1
Regis College - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Oncology (Williston Park, N.Y.), ISSN 0890-9091, 06/2012, Volume 26, Issue 6, pp. 568 - 570
Journal Article
The New England journal of medicine, ISSN 1533-4406, 07/2015, Volume 373, Issue 4, pp. 307 - 316
Journal Article
The lancet oncology, ISSN 1470-2045, 2011, Volume 12, Issue 12, pp. 1134 - 1142
Journal Article
Breast (Edinburgh), ISSN 0960-9776, 11/2019, Volume 48 Suppl 1, pp. S21 - S22
In identifying research priorities it is important to take the needs and prospective of patients with breast cancer into account. 
Female | Research | Health Services Needs and Demand - trends | Breast Neoplasms | Humans | Patient Participation | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2010, Volume 11, Issue 1, pp. 55 - 65
Journal Article
The lancet oncology, ISSN 1470-2045, 2011, Volume 12, Issue 3, pp. 236 - 244
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 02/2012, Volume 366, Issue 6, pp. 520 - 529
Resistance to hormone therapy through activation of cellular pathways involving mTOR can develop in postmenopausal hormone-receptor–positive breast cancer.... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Recurrence | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Bone Neoplasms - secondary | TOR Serine-Threonine Kinases - antagonists & inhibitors | Aromatase Inhibitors - adverse effects | Breast Neoplasms - chemistry | Aged, 80 and over | Postmenopause | Adult | Female | Aromatase Inhibitors - therapeutic use | Everolimus | Sirolimus - adverse effects | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Kaplan-Meier Estimate | Receptor, Epidermal Growth Factor - analysis | Breast Neoplasms - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Stomatitis - chemically induced | Aged | Androstadienes - therapeutic use | Androstadienes - adverse effects | Drugs | Care and treatment | Usage | Hormone therapy | Patient outcomes | Drug utilization | Breast cancer | Product/Service Evaluations | Drug therapy, Combination | Drug therapy | TOR protein | Anastrozole | Endocrine therapy | Fatigue | Intracellular signalling | Rapamycin | Tamoxifen | Cancer therapies | Survival | Post-menopause | Fulvestrant | Signal transduction | Stomatitis | Hyperglycemia | Chemotherapy | Pneumonitis | Dyspnea | Aromatase | Antitumor activity | Respiration | Index Medicus | Abridged Index Medicus
Journal Article